Creatine Monohydrate Supplement

## What it is Creatine is a nitrogenous organic acid synthesized in the liver, kidneys, and pancreas from arginine, glycine, and methionine. The body produces roughly 1 gram per day endogenously, and an omnivorous diet supplies another 1 to 2 grams from red meat and fish. Roughly 95% of the body's creatine pool sits in skeletal muscle, where it is phosphorylated to phosphocreatine and serves as a rapid-turnover ATP buffer. Creatine monohydrate is the form used in essentially every published efficacy trial. It was first isolated from meat extract by the French chemist Michel Eugene Chevreul in 1832. Commercial supplementation began in the early 1990s after work by Roger Harris and Eric Hultman at Karolinska Institutet established that 5 grams four times daily for five to seven days could raise intramuscular total creatine by roughly 20%. The 1992 Barcelona Olympics is the unofficial inflection point at which creatine moved from research curiosity to mainstream sports supplement. Legally it is a dietary supplement in most jurisdictions. WADA permits it. The International Society of Sports Nutrition position stand (Kreider 2017) is the cleanest single summary of the evidence base and the document most reviewers cite when asked for a starting reference. There is no patent on creatine monohydrate, which means the price floor is low and brand premiums are functionally cosmetic. ## Mechanism of action The bioenergetic role is straightforward. ATP hydrolysis powers muscle contraction, but skeletal muscle stores only enough ATP for roughly 2 to 3 seconds of maximal effort. The phosphocreatine system regenerates ATP from ADP via the creatine kinase reaction, extending maximal-output capacity to roughly 10 to 15 seconds. Supplementation raises the total creatine pool by 10 to 40% (with larger gains in vegetarians and those with low baseline stores) and the phosphocreatine fraction proportionally. The downstream consequence is a measurably higher work output across repeated short, intense efforts. Uptake into muscle is mediated by the SLC6A8 sodium- and chloride-dependent creatine transporter. Insulin upregulates SLC6A8 expression, which is the mechanistic basis for the long-standing recommendation to dose creatine with carbohydrates. The effect on absorption is real but modest, on the order of a 10 to 20% increase in retention. Most contemporary protocols ignore it because the saturation ceiling is reached on schedule either way. Creatine is metabolized to creatinine non-enzymatically at a rate proportional to the total pool, which is why supplemented users often run serum creatinine 0.1 to 0.3 mg/dL above their pre-supplementation baseline. This is a confounder for eGFR estimates, not a sign of renal injury. Methods that rely on cystatin C or measured GFR are unaffected. Beyond the sarcomere, creatine and phosphocreatine play smaller but measurable roles in brain bioenergetics. The creatine kinase isoform CKBB is expressed in neurons and astrocytes, and brain phosphocreatine pools turn over on the same timescale as skeletal muscle. The cognitive effects observed under sleep deprivation and high mental load are most parsimoniously explained by the same energy-buffering mechanism applied to a tissue under acute metabolic stress. ## Evidence base by outcome ### Strength and 1RM The meta-analytic average across 25 to 35 trials in resistance-trained adults is a 5 to 15% improvement in 1-rep max on bench press and squat versus placebo over 4 to 12 weeks. Syrotuik 2004 is a clean exemplar: 34 trained men, 5 g/day for 12 weeks, 3.7% bench press 1RM gain versus 1.1% on placebo (p less than .05). The Rawson and Volek 2003 meta-analysis (96 studies pooled across populations) put the strength advantage at roughly 8% above placebo. Effects are larger in untrained or detrained populations, where there is more headroom, and smaller but still significant in elite athletes. ### Lean body mass Most trials report a 1 to 2 kg gain in lean body mass over 4 to 12 weeks of training plus supplementation. The first kilogram is largely intracellular water, expected from the osmotic effect of higher muscle creatine concentration. The remainder is true tissue accretion driven by larger training volumes and faster recovery between sessions. The split between water and tissue is hard to disentangle in DEXA studies, which is why the field has settled on reporting the combined gain rather than fractionating it. ### High-intensity exercise capacity Wingate-style anaerobic tests show 5 to 15% improvements in peak and mean power output across 25 controlled trials. The effect is largest on repeat-sprint protocols where phosphocreatine recovery between bouts is rate-limiting, and smaller on single-effort tests. Sport-specific outcomes follow the same pattern: reliable benefit in repeat-sprint sports (rugby, soccer, hockey), smaller benefit in time-trial endurance work where the limiting fuel is carbohydrate or fat oxidation rather than the phosphagen system. ### Cognition The cognitive evidence is weaker than the muscle evidence and concentrated in two scenarios: sleep deprivation and vegetarianism. Gordji-Nejad 2024 (n=15, single 35 g dose) reported faster reaction time and improved working memory after 21 hours of sleep deprivation. Earlier work by Rae 2003 in vegetarians reported memory and intelligence-test gains at 5 g/day for 6 weeks. In well-rested omnivores at typical maintenance doses, cognitive benefits are small and inconsistent. Use creatine for muscle outcomes; treat the cognitive effect as a bonus that may show up under metabolic stress. ### Recovery and other outcomes Post-eccentric exercise creatine kinase and lactate dehydrogenase markers run lower in supplemented groups, suggesting a real recovery effect. Bone mineral density gains in postmenopausal women combining creatine with resistance training are small but reproducible (Chilibeck 2015). The fatigue signal in depression as an SSRI adjunct (Lyoo 2012) is real but small and shouldn't be the headline use case. ## Dosage and protocols The standard maintenance dose is 3 to 5 g/day, taken at any time, with or without food. There is no meaningful evidence that timing matters once stores are saturated. The optional loading phase is 20 g/day split into 4 doses of 5 g for 5 to 7 days, which reaches saturation in roughly a week instead of the four weeks required at 5 g/day. Loading is harmless and accelerates the timeline by three weeks; skipping it costs three weeks and has lower GI side-effect risk. Either approach reaches the same steady-state plateau. No cycling is required. The transporter does not downregulate meaningfully with chronic use, and the muscle creatine pool stays elevated as long as supplementation continues. After cessation it returns to baseline over 4 to 6 weeks. Larger body size warrants a slightly higher maintenance dose. Roughly 0.03 g/kg/day is a defensible scaling rule, which lands a 100 kg lifter at 3 g/day and a 60 kg endurance athlete at closer to 2 g/day. Doses above 5 g/day in well-saturated users have no demonstrated benefit and increase the chance of GI symptoms and water retention. ## Side effects and safety The most common reported side effect is mild GI upset, usually associated with loading doses or with poor-quality powders that fail to dissolve. Splitting the loading dose across four servings and pairing each with a meal essentially eliminates the issue. The 1 to 2 kg of intracellular water gain is sometimes reported as bloating, but it is intracellular muscle water rather than subcutaneous water, and it is the mechanism rather than a side effect. Serum creatinine elevation of 0.1 to 0.3 mg/dL is expected. In clinical settings this can cause spurious flags on routine bloodwork or eGFR calculations. The fix is either measuring cystatin C or pausing creatine for 4 to 6 weeks before testing kidney function. Long-term studies in healthy adults out to 5 years have not detected renal impairment. The standing recommendation in pre-existing severe renal disease is to consult a nephrologist rather than start without guidance, not because of strong evidence of harm but because the population has been underrepresented in trials. The theoretical interaction with nephrotoxic drugs (NSAIDs, cyclosporine, aminoglycosides) is similarly precautionary rather than evidence-based. The case reports of harm in the literature are vanishingly few given how widely creatine is consumed. ## Stack interactions and timing Creatine combines well with most ergogenic aids. Beta-alanine targets a different fuel system (carnosine buffering of intramuscular pH) and the two stack additively in trials. Caffeine has shown mixed acute-interference effects in older work, but chronic use of both is well-tolerated and the negative interaction does not replicate consistently. Whey protein post-workout is the most common pairing and the insulin response from a mixed meal modestly assists uptake. Timing within the day is largely irrelevant once muscle stores are saturated. The defensible heuristic is to take it post-workout with a carbohydrate-and-protein meal, mostly because it is a habit that is hard to forget. Pre-workout dosing offers no demonstrated acute benefit because the absorption window does not align with the workout. ## Practical notes Buy plain creatine monohydrate. Micronized versions dissolve more cleanly but are not bioavailability-enhanced. Buffered forms (Kre-Alkalyn), creatine HCl, and creatine ethyl ester have all been tested head-to-head against monohydrate and have shown either parity or inferiority. The Creapure brand is German-manufactured and is the most commonly third-party-verified raw material; it is not necessary, but it is the lowest-friction sourcing decision. Storage is straightforward. The dry powder is stable for years at room temperature. Once dissolved in water it slowly degrades to creatinine, so do not pre-mix shakes the night before. A scoop in your shaker minutes before drinking is fine. Cost per dose is roughly 5 to 15 cents at standard retail and substantially less in bulk. Expect noticeable changes by week 2 to 4. Strength and lean-mass effects compound over training cycles, not days. If you have not seen any change by 8 weeks of consistent training and dosing, the limiting factor is almost certainly training volume or sleep, not the supplement.